Cases of COVID-19 continue to surge in communities across Canada, with Ontario recording its biggest single-day increase on Saturday.
Ontario reported 978 more cases of COVID-19, with nearly 44,200 tests completed, two weeks after the Thanksgiving holiday weekend.
Saturday’s count of new cases surpassed the previous high of 939, reported on Oct. 9.
Locally, there are 348 new cases in Toronto, 170 in Peel Region, 141 in York Region, 89 in Ottawa and 51 in Durham Region.
Ontario reported 826 new cases of COVID-19 on Friday and nine new deaths linked to the virus.
Quebec on Saturday reported 1,009 new cases and 26 more deaths, after recording 905 new COVID-19 cases and 12 deaths the previous day.
As of Friday, there were 540 people in hospital, including 99 in intensive care. In its latest projections, the province’s national health institute said hospitals will not reach full capacity in the next four weeks due to the rate of transmission having stabilized in recent days.
WATCH | COVID-19 cases threaten to overwhelm Canadian hospitals, doctor says
CBC medical contributor Dr. Peter Lin stresses the need to make sure hospitals are equipped to deal with the resurgence in coronavirus cases. 8:42
Premier François Legault has said it’s likely the province will have to maintain many public health restrictions currently in place in red zones past Oct. 28, including keeping restaurants and bars closed.
Dr. Theresa Tam, Canada’s chief public health officer, issued a statement on Saturday reiterating her warning from the previous day that the number of people “experiencing severe illness” due to the pandemic continues to rise.
“As hospitalisations and deaths tend to lag behind increased disease activity by one to several weeks, the concern is that we have yet to see the extent of severe impacts associated with the ongoing increase in COVID-19 disease activity,” Tam said.
“As well, influenza and respiratory infections typically increase during the fall and winter, placing increased demands on hospitals. This is why it is so important for people of all ages to maintain public health practices that keep respiratory infection rates low.”
WATCH | Reduce gatherings even more, health experts urge:
British Columbia’s Provincial Health Officer Dr. Bonnie Henry expressed concerns around the spread of COVID-19 at social gatherings, something that infectious diseases specialist Dr. Sumon Chakrabarti says is being seen across the country. 1:54
“Over the past seven days, there was an average of just over 1,000 individuals with COVID-19 treated in Canadian hospitals, including over 200 in critical care,” Tam said.
Cases of COVID-19 continue to surge in communities across Canada, with Ontario and Quebec remaining the hardest-hit provinces; however, other provinces are seeing record increases.
Alberta reached the grim figure of 300 COVID-19 deaths on Friday while setting records yet again for new cases and active cases.
The province reported 432 new cases and 3,651 active cases, the third straight day records were set.
Fifty inmates and five staff members at the Calgary Correctional Centre have tested positive for the infection, according to a statement from Alberta Health Services.
All inmates and staff are being tested, and isolation and monitoring of the positive cases are underway. Contact tracing for anyone potentially exposed to these individuals is ongoing.
What’s happening elsewhere in Canada
As of 12:50 p.m. ET on Saturday, Canada had 212,750 confirmed or presumptive coronavirus cases. Provinces and territories listed 179,537 of those as recovered or resolved. A CBC News tally of deaths based on provincial reports, regional health information and CBC’s reporting rose to 9,920.
Prime Minister Justin Trudeau updated Canadians on vaccine development Friday — a day after Canada tallied a record high of new cases in a single day at 2,788 — saying the federal government is spending $214 million toward the development of COVID-19 vaccines, signing deals with two Canadian biotech firms.
Trudeau warned it’s unlikely that any of these candidates will be ready to distribute to Canadians this year or early next year. It’s reasonable to expect that vaccines will start to roll out at some point in 2021, he said, but even then, supply will be limited, and high-risk populations will be prioritized for inoculation.
Trudeau said his government signed a $173 million contract with Quebec’s Medicago to secure the rights to buy 76 million doses of its vaccine, should it meet health and safety standards. The funding will also be used to establish a production facility in Quebec City, he said.
Ottawa is also investing $18.2 million in a potential vaccine from British Columbia’s Precision NanoSystems. Meanwhile, the National Research Council is spending $23 million to support other Canadian vaccine initiatives, Trudeau said.
WATCH | Study casts doubt on use of convalescent plasma for COVID-19 treatment:
An Indian study is casting doubt on the effectiveness of giving patients sick with COVID-19 the blood plasma of others who have battled it, to transfer antibodies. But Canadian researchers say it could still work, if the antibody levels are tested. 3:27
The prime minister said Canada has signed six agreements with a number of companies taking part in the global race to produce a safe and effective vaccine for COVID-19 .
Two more American vaccine makers, Moderna and Pfizer, have asked Health Canada to review their products, which are undergoing clinical trials.
In British Columbia, health officials announced 223 new cases of COVID-19 on Friday. Seventy-five people are in hospital, with 24 in intensive care.
Yukon‘s chief medical officer of health, Dr. Brendan Hanley, has reported three new cases in Watson Lake, which he says are part of a “family cluster.” They hadn’t travelled outside Yukon, so it’s not known yet where they contracted the virus.
WATCH | Manitoba’s top doctor on the increasing community spread of COVID-19:
Dr. Brent Roussin, Manitoba’s chief public health officer, explains why increasing community spread of COVID-19 makes targeted approaches to control the illness less effective. 0:48
Manitoba reported a total of 163 new infections on Friday, most concentrated in Winnipeg. The province also said a man in his 80s is the latest death linked to an outbreak at Winnipeg’s personal care home Parkview Place, where 15 residents have died of the illness.
The province has announced new rules for northern Manitoba and schools in both the Winnipeg area and the north. Those measures will take effect on Monday.
Nova Scotia reported no new cases of COVID-19 on Friday, a day after the province warned residents against unnecessary travel to the Campbellton-Restigouche area of New Brunswick due to a COVID-19 outbreak.
The recommendation came after New Brunswick announced new restrictions for the Campbellton region, almost two weeks after it was pushed back to the orange phase of recovery. While Zone 5 will remain in the orange stage, people will be limited to interacting with a single household bubble, N.B. Chief Medical Officer of Health Dr. Jennifer Russell said.
New Brunswick announced two new COVID-19 cases on Saturday, in addition to two new cases on Friday. That brings the total number of cases the province has recorded to 326, with four deaths.
Newfoundland and Labrador reported one new confirmed case of COVID-19 on Saturday, a man from the Eastern Health region in his 50s who had returned home to the province after working in Alberta.
Out of an abundance of caution, the province’s Health Department is asking passengers who travelled on Air Canada Flight 690 from Toronto to St. John’s last Tuesday to arrange for COVID-19 testing.
What’s happening around the world
According to Johns Hopkins University in Baltimore, the global total of confirmed coronavirus cases stands at more than 42.2 million. More than 1.1 million people have died, while more than 28.5 million have recovered.
In Europe, Polish President Andrzej Duda has tested positive for coronavirus, his spokesperson says. Duda’s diagnosis comes amid a huge surge in the number of confirmed cases of COVID-19 and deaths in Poland, pushing the country’s strained health system to the breaking point. The government is preparing to open field hospitals, but it is not sure where it will find the doctors and nurses to staff them.
In the Americas, the U.S. hit a daily record of coronavirus cases on Friday with more than 84,000 reported infections, thousands more than the previous peak in July. The numbers are an ominous sign the disease still has a firm grip on the nation that has more confirmed virus-related deaths and infections than any other in the world. Many states are reporting a surge of cases and say hospitals are running out of space in areas where the pandemic seemed remote only months ago.
In Asia, authorities in Sri Lanka closed at least two fishery harbours and many stalls after a surge of 609 cases linked to the country’s main fish market. Authorities say the outbreak is related to a cluster in a garment factory early this month, which has grown to 3,426 cases, almost half the country’s total of 6,287. Several thousand people have been asked to quarantine at home.
In Africa, the Ethiopian attorney general’s office said authorities can jail people for up to two years if they deliberately violate restrictions amid concerns that citizens are becoming lax after a state of emergency was lifted. The country has seen more than 91,000 cases and more than 1,300 deaths.
Have a coronavirus question or news tip for CBC News? Email us at COVID@cbc.ca
NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.
The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.
Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.
“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”
More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.
Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.
The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.
However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.
Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.
“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.
What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.
In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.
Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.
Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.
Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.
However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.
Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.
Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)
There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.
“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.
That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.
Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.
“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.
Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.
When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.
The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.
The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.
Worldwide, around 585 volcanoes are considered active.
Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.
Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.
(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.
The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.
After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.
Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.
Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.
“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.
Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.
But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.
Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.
Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.
Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.
That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.
Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.
Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.